Ignite Creation Date:
2025-12-24 @ 7:40 PM
Ignite Modification Date:
2025-12-30 @ 12:46 AM
Study NCT ID:
NCT02449603
Status:
COMPLETED
Last Update Posted:
2018-11-14
First Post:
2015-05-11
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Comparison of Exenatide vs. Biphasic Insulin Aspart 30 on Glucose Variability in Type 2 Diabetes
Sponsor:
Xijing Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-11
Start Date Type:
ACTUAL
Primary Completion Date:
2018-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-04
Completion Date Type:
ACTUAL
First Submit Date:
2015-05-11
First Submit QC Date:
None
Study First Post Date:
2015-05-20
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-11-11
Last Update Post Date:
2018-11-14
Last Update Post Date Type:
ACTUAL